-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Heart failure (HF) is a potentially life-threatening complication of childhood cancer treatment, and the effects of low-dose drug therapy are currently poorly
The study included children diagnosed with cancer survivors aged 5 years and older between 1940 and 2009 in seven European countries (n=42361).
The results showed that by the age of 50, the cumulative incidence of heart failure was 2%.
As for the total cumulative dose of anthracyclines, the risk of heart failure was significantly increased in survivors receiving ≥ 100 mg/m2, while the risk of heart failure was significantly increased
In summary, cancer survivors with an average cardiac radiation dose of ≥ 5 Gy have an increased
Original Source:
Esmée C.